P

Poltreg SA
WSE:PTG

Watchlist Manager
Poltreg SA
WSE:PTG
Watchlist
Price: 26.5 PLN 1.92% Market Closed
Market Cap: zł123.5m

Operating Margin

-10 123.6%
Current
Declining
by 6 697.5%
vs 3-y average of -3 426.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-10 123.6%
=
Operating Income
zł-25.3m
/
Revenue
zł250k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-10 123.6%
=
Operating Income
zł-25.3m
/
Revenue
zł250k

Peer Comparison

Country Company Market Cap Operating
Margin
PL
Poltreg SA
WSE:PTG
121.3m PLN
Loading...
IN
Aaswa Trading and Exports Ltd
BSE:512038
24.5T INR
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
GE Vernova LLC
NYSE:GEV
182.8B USD
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
US
Schlumberger NV
NYSE:SLB
74.1B USD
Loading...
US
Baker Hughes Co
NASDAQ:BKR
55.2B USD
Loading...
IN
GTV Engineering Ltd
BSE:539479
4.8T INR
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
49.2B USD
Loading...
CH
Galderma Group AG
SIX:GALD
35.2B CHF
Loading...
US
Reddit Inc
NYSE:RDDT
41.7B USD
Loading...

Market Distribution

Lower than 97% of companies in Poland
Percentile
3nd
Based on 835 companies
3nd percentile
-10 123.6%
Low
-10 083 900% — -1.5%
Typical Range
-1.5% — 11.7%
High
11.7% — 195 905.3%
Distribution Statistics
Poland
Min -10 083 900%
30th Percentile -1.5%
Median 5.4%
70th Percentile 11.7%
Max 195 905.3%

Poltreg SA
Glance View

Market Cap
123.5m PLN
Industry
N/A

PolTREG SA develops and commercializes patented TREG methods. The company is headquartered in Gdansk, Woj. Pomorskie and currently employs 11 full-time employees. The company went IPO on 2021-11-23. The firm conducts research in the field of autoimmunological diseases. The firm works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The firm works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The firm is developing its own research center, which is intended as a basic location for conducting future research activities.

PTG Intrinsic Value
1.11 PLN
Overvaluation 96%
Intrinsic Value
Price
P
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-10 123.6%
=
Operating Income
zł-25.3m
/
Revenue
zł250k
What is Poltreg SA's current Operating Margin?

The current Operating Margin for Poltreg SA is -10 123.6%, which is below its 3-year median of -3 426.1%.

How has Operating Margin changed over time?

Over the last 3 years, Poltreg SA’s Operating Margin has decreased from -359.4% to -10 123.6%. During this period, it reached a low of -10 123.6% on Jul 30, 2025 and a high of -359.4% on May 30, 2022.

Back to Top